Argon Medical Devices, Inc

Argon Medical Devices Announces The Launch Of OptionELITE Retrievable Vena Cava Filter And The Acquisition of Angiotech Interventional Business

argon_admin — Thu, 04 Apr 2013 16:23:48 +0000

4/4/2013 6:25 AM

PR Newswire

PLANO, Texas, April 4, 2013 /PRNewswire/ — Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter. The OptionELITE IVC Filter, designed by Rex Medical, LP, provides the clinician with the same safe and trusted design now enhanced for ease of delivery and retrievability.

“Safety and retrievability are without question two of the most vital, and rare, characteristics in a best-in-class retrievable IVC filter. Argon is pleased to be able to offer the best of these worlds by introducing the OptionELITE,” stated George Leondis, President of Argon Medical Devices. “This technology provides clinicians with a safe and stable IVC filter that can be confidently deployed and retrieved while minimizing the risk of migration, penetration and fracture. This product, along with the new Cleaner15™ Mechanical Thrombectomy System, and the recently announced acquisition of Angiotech’s Interventional business, positively positions the company as a significant player in the interventional arena.”

OptionELITE’s enhanced retention anchor pattern provides stability and reduced retrieval force while preventing migration and reducing the risk of penetration. The sturdy apex design has an increased capture zone for ease of snaring. In addition, the new high performance spiral sheath remains the lowest profile IVC filter delivery system available today (6.5Fr OD, 5.0Fr ID) and has been reinforced for improved kink-resistance and pushability.

“I have used Option™ for many years. At Weill Cornell, we had the opportunity to participate in the OptionELITE evaluation and found the device to be just as safe and stable as the Option, with no migrations and significantly easier to retrieve,” saidDavid W. Trost, MD, Associate Professor of Clinical Radiology, Weill Medical College of Cornell University in New York, New York.

Argon Medical will be featuring the OptionELITE IVC Filter at the 38th Annual Scientific Meeting of the Society of Interventional Radiology in New Orleans, Louisiana, April 13 – 18, 2013 and will be offering a hands-on simulator training experience at booth 840.

PE affects an estimated 600,000 to 1,000,000 people in the US and its incidence is increasing annually. PE is the sudden blockage of an artery in the lung (pulmonary artery) typically blood clot (thrombus). Emboli dislodgement can be caused by peripheral vascular disease (PVD), severe deep vein thrombosis (DVT), trauma and prolonged immobilization often following major surgical procedures. PE occurs when these clots break loose and embolize to block pulmonary blood vessels in the lungs. According to clinical research, if left untreated, PE has a mortality rate of 30% and is a leading cause of inpatient deaths in US hospitals.

About Argon

Argon Medical Devices is a global manufacturer of specialty medical products headquartered in Plano, Texas. Argon offers a diverse line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures. Its products include the Option™ELITE Retrievable Vena Cava Filter, Cleaner Rotational Thrombectomy Systems, and the UltraStream™ Chronic Dialysis Catheter. The recently announced acquisition of Angiotech’s Interventional business, brings best -in-class products such as BioPince™ Full Core Biopsy Instruments, Skater™ All-Purpose Drainage Systems, and Atrieve Vascular Snare™ Kits, into the Argon product portfolio. Argon Medical Devices is a privately held portfolio company of Roundtable Healthcare Partners, which is committed to providing clinicians with innovative, technology-driven solutions to improve patient outcomes.

About Roundtable

RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry. The partners of RoundTable have significant experience in managing, operating, acquiring and financing multibillion-dollar diversified health-care companies. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.

About Rex Medical, LP

Rex Medical, LP, based in Conshohocken, PA, is a privately held medical device company specializing in the development, manufacturing and marketing of minimally invasive medical devices targeted towards the cardiovascular, venous access, endosurgery and oncology markets. Rex Medical is ISO 13485 certified.

SOURCE Argon Medical Devices, Inc.

RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals’ Interventional Products Business

argon_admin — Mon, 25 Mar 2013 19:49:10 +0000

LAKE FOREST, IL, MARCH 25, 2013 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon” or the “Company”), entered into a definitive agreement to acquire the Interventional Products Business of Angiotech Pharmaceuticals, Inc. (“Angiotech”). The Interventional Products Business manufactures and markets disposable and re-usable biopsy products for the diagnosis of cancer, drainage catheter products, and vascular interventional products. The transaction is expected to be completed prior to the end of April 2013 subject to customary closing conditions.

The acquisition of the Interventional Products Business bolsters Argon’s existing portfolio of interventional vascular products, adds additional biopsy product lines, and further leverages the Company’s sales force within core call points. As part of the transaction, Argon will also acquire three dedicated manufacturing facilities in Wheeling, IL; Gainesville, FL; and Rochester, NY. Argon currently manufactures its products in facilities in Athens, TX and Singapore.

“The Interventional product franchise is well recognized by hospitals and physicians worldwide,” said Michael J. Hudson, CEO of Argon. “The acquisition of these products strengthens the Argon portfolio and cements our Company’s position as a key player in the Interventional Radiology, Cardiac Catheterization and Vascular Surgery markets.”

The Interventional Products Business was created by RoundTable in 2003 as part of its American Medical Instruments Holdings, Inc. (“AMIH”) investment. The AMIH business was run by Argon’s current management team including: Michael Hudson, Argon’s CEO; Richard Adloff, Argon’s CFO; and George Leondis, Argon’s President. AMIH combined the formerly independent Manan Medical, MD Tech, PBN Medical, and American Medical Instruments into a consolidated operating unit. Angiotech acquired the Interventional Products Business from RoundTable in 2006 as a part of its purchase of AMIH.

“We are extremely excited to own the business again,” added Joseph F. Damico, Founding Partner and Co-Chairman of RoundTable. “Our significant history with this excellent management team in the interventional segment, along with our in-house resources in sales and manufacturing will assist the Argon team in effectively integrating these two businesses to position the combined company for significant growth.”

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model. RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million. More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.

About Argon Medical Devices

Founded in 1972, Argon is a global manufacturer of specialty medical products headquartered in Plano, Texas. Argon offers a broad line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures. Current products include the Option™ Retrievable Inferior Vena Cava Filter, Cleaner Rotational Thrombectomy System, and UltraStream™ Chronic Dialysis Catheter. Argon also offers a complete line of PICC and midline catheters, endomyocardial biopsy forceps, introducer sheaths, pressure transducers, and other vascular products. The Company’s products are sold globally through a combination of direct sales representatives and premier specialty distributors. For more information on Argon, please visit www.argonmedical.com.

Argon Medical Devices, Inc. Announces the Launch of the Cleaner15™ Rotational Thrombectomy System

argon_admin — Wed, 16 Jan 2013 14:07:25 +0000

Plano, TX, January 16, 2013 – Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15™ Rotational Thrombectomy System. The addition of Cleaner15™ to Argon Medical’s product portfolio provides physicians with another weapon in their arsenal to safely and effectively restore patency in occluded arteriovenous fistulae and synthetic grafts.

“We are excited to introduce this leading-edge addition to the Cleaner line of devices,” commented George A. Leondis, President of Argon. “The introduction of Cleaner15™ illustrates Argon’s commitment to providing best-in-class technologies that enable clinicians to improve outcomes for patients undergoing mechanical thrombectomy procedures.”

The Cleaner15™ Rotational Thrombectomy System utilizes a 15mm single, sinusoidal wire that allows for safe and effective thrombus removal. The 0.044 wire combined with the increase in torque provides the physician with the power needed for difficult declot cases resulting in reduced procedure time, along with enhanced steerability in tight stenoses and aneurysms. (Cleaner15™ Rotational Thrombectomy System is designed and manufactured by Rex Medical, L.P., Conshohocken, PA).

“The Cleaner15™ technology provides efficiency and robust power in challenging thrombectomy cases. The radial force of the sinusoidal wire engages thrombus and has the ability to expand to 15mm allowing for maceration of thrombus effectively, while maintaining procedural safety. I feel very comfortable using the device in all applications including stents and venous valves without risk of binding,” stated Dr. Mark Goldberg, MD, Medical Director of the Center for Dialysis Access, Oakwood, OH.

Argon Medical will be exhibiting at the 25^th Annual International Society of Endovascular Therapy (ISET) Scientific Meeting to be held in Miami, FL from January 19^th thru the 23rd at the Fontainebleau Miami Beach.

Nearly 600,000 patients currently undergo treatment in the U.S. for End-Stage Renal Disease (ESRD). In addition, over 300,000 procedures are being performed annually in the U.S. to repair and clear thrombosed hemodialysis access grafts and fistulae. It is estimated that the dialysis patient population will continue to grow at a rate exceeding 6% annually.

About Argon

Founded in 1972, Argon Medical is a global manufacturer of specialty medical products headquartered in Plano, Texas. Argon offers a broad line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures. Current products include the Option™ Retrievable Inferior Vena Cava Filter, Cleaner Rotational Thrombectomy System, and UltraStream™ Chronic Dialysis Catheter. Argon also offers a complete line of PICC and midline catheters, endomyocardial biopsy forceps, introducer sheaths, pressure transducers, and other vascular products. Our products are sold globally through a combination of direct sales representatives and premier specialty distributors.

About Roundtable

Roundtable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry. The partners of Roundtable have significant experience in managing, operating, acquiring and financing multibillion-dollar diversified health-care companies.

LiDCOrapid Registration Japan

argon_admin — Tue, 29 May 2012 14:55:51 +0000

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, is pleased to announce that Argon Medical (LiDCO’s partner in Japan) has confirmed that the LiDCOrapid Monitor and associated disposable products have been successfully approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). LiDCO believes that Japan is the second largest market in the world for hemodynamic monitoring with approximately 680,000 high-risk surgical patients per annum who would benefit clinically from improved intraoperative fluid management.

The LiDCO products will be shown at the forthcoming Japanese Anesthetic Society Meeting in Kobe on the 7^th – 9^th of June.

Dr Terry O’Brien, CEO of LiDCO, commented: “We are delighted that our partner Argon Medical has successfully concluded the approval process in Japan and will be promoting the product in the very near future. Minimally invasive hemodynamic monitoring in Japan has a potential market value of US$285 million per annum. We greatly welcome the substantial market opportunity this presents for LiDCO’s fluid monitoring technology.”

George A. Leondis, President of Argon Medical Devices, Inc added: “We are pleased to have received this most important approval. This next generation technology expands our critical care portfolio, offering clinicians a versatile, new and more effective option in minimally invasive, hemodynamic monitoring.”

Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter

argon_admin — Fri, 23 Mar 2012 16:02:03 +0000

PLANO, Texas, March 22, 2012 – Argon Medical Devices, Inc. announced today the US launch of the UltraStream Chronic Hemodialysis catheter, licensed from Rex Medical, LP, designed to provide long-term vascular access to patients receiving dialysis treatments.

“UltraStream provides clinicians with an innovative tool to improve care and quality of life for their patients,” commented George Leondis, President of Argon. “This unique technology broadens our dialysis platform and highlights our commitment to this growing disease state.”

The UltraStream Chronic Hemodialysis catheter is the only Chronic Dialysis catheter available with innovative dual lumen arterial lines and a modified step tip design that allow for high flow rates and ease of insertion, providing the combination of clinician satisfaction and improved patient outcomes. This exclusive step tip design allows for placement, both over the wire, and through a peel-away sheath. The seamless transition from the dilator to the step tip facilitates easier catheter exchanges.

UltraStream catheters are provided in a variety of set configurations to meet physician preferences.

There are currently over 571,000 patients diagnosed and treated for End-Stage Renal Disease, with over 116,000 newly diagnosed patients in 2009.* This 3.5% increase in ESRD is the highest since 2000.

About Argon

Argon Medical is a global manufacturer of specialty medical products headquartered in Plano, Texas. We offer a broad line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures. Our newest products include the Option(TM) Retrievable Inferior Vena Cava Filter, Cleaner Rotational Thrombectomy System, and UltraStream Chronic Dialysis Catheter. We also offer complete lines of PICC and midline catheters, endomyocardial biopsy forceps, introducer sheaths, pressure transducers, and other vascular products. Our products are sold globally through a combination of direct sales representatives and premier distributors.

About Roundtable

About Rex

* 2011 USRDS Annual Data Report – United States Renal Data System

LiDCO signs LiDCOrapid monitor Registration and Supply Agreement for Japan with Argon Medical Devices Japan, K.K.

argon_admin — Thu, 07 Jul 2011 23:01:54 +0000

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with Argon Medical Devices, Japan, K.K. (“Argon Medical”) to register with the Japanese Ministry of Health, Labour and Welfare the LiDCOrapid monitor and disposable kit for the Japanese market.

Argon Medical designs, manufactures and sells single-use specialty medical device disposables and in September 2010 acquired the critical care business of Becton, Dickinson (“BD”).

Dr Terry O’Brien,CEOof LiDCO, commented: ”We are delighted to sign this agreement with Argon Medical and commence the regulatory approval process for the Japanese market. Minimally invasive hemodynamic monitoring is becoming well established in Japan and the Board believes that the Japanese hemodynamic monitoring high risk surgery market has a potential market value of US$285 million per annum, with reimbursement available. Through our partnership with Argon Medical Devices Japan, LiDCO will be well positioned to capitalize on this.”

George Leondis, President of Argon Medical Devices, Inc added: ”We are very pleased to again collaborate with LiDCO. Our partnership on this groundbreaking technology is a significant step forward in the growth of Argon’s Critical Care business in Japan.”

About LiDCO Group Plc

LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO’s products facilitate the application of hemodynamic optimization protocols for high risk patients in both critical care units and in the operating theatre.

Increasingly clinical studies are showing that the optimization of patients’ hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO’s computer-based technology, developed at St Thomas’ Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

Argon Medical Devices Announces Exclusive License And Distribution Agreement For Option™ Retreivable Inferior Vena Cava Filter

argon_admin — Tue, 15 Mar 2011 13:19:04 +0000

ATHENS, TX, March 15^th, 2011 – Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP (“Rex Medical”) for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).

“We are very pleased with the addition of Option™ to our product portfolio. This proven technology has rapidly become a leader in this disease segment due both to its efficacy and safety, and we are confident it will prove to be the preferred device of its kind,” said George A. Leondis, President of Argon Medical Devices, Inc. “This partnership provides a compelling strategic opportunity for Argon, allowing us to provide our customers with another best in class product in the Interventional arena.”

“Rex Medical is looking forward to again collaborating with Argon, on this innovative and pivotal technology,” commented Lindsay L. Carter, President of Rex Medical, LP. “Argon’s focused commitment to its customerbase, coupled with its global sales and marketing presence and corresponding operational capabilities, make it the ideal partner.”

Argon will be exhibiting at the 36th Annual Society of Interventional Radiology (SIR) Scientific Meeting, to be held in Chicago, IL from March 27-30, 2011.

About the Option™ Inferior Vena Cava Filter

The nitinol, Option™ IVC Filter, with a low profile 5Fr (6.5Fr O.D.) delivery system, is designed to be implanted into the inferior vena cava of patients to prevent recurrent PE. The filter is designed with symmetric flared struts to direct clot volume into the center of the vessel for maximum dissolution and preservation of blood flow allowing for capture of clinically significant clot and protection against PE. Designed as both a permanent or retrievable implant, this self-centering IVC filter promotes optimal positioning and stability within the inferior vena cava. Its intuitive, easy-to-use design, makes Option’s™ deployment and retrieval safe and effective.

About Pulmonary Embolism (PE)

PE is an extremely common and highly lethal condition that is a leading cause of death in all age groups. PE is the sudden blocking of an artery of the lung (pulmonary artery) by a collection of solid material transferred through the bloodstream (embolus)—usually a blood clot (thrombus) or rarely other foreign material. PE occurs when these clots break loose and embolize to block pulmonary blood vessels in the lungs. PE affects an estimated 600,000 to 1,000,000 people in the US, and its incidence is increasing annually due mainly to the aging population. According to clinical research, if left untreated, PE has a mortality rate of 30% and is a leading cause of in-patient deaths in U.S. hospitals. Emboli dislodgement can be caused by peripheral vascular disease (PVD), severe deep vein thrombosis (DVT), trauma and, prolonged immobilization often following major surgical procedures.

About Argon

Argon Medical Devices, Inc., based in Athens, TX, is a privately-held global medical device company which manufactures and markets solutions for cardiovascular, venous access and critical care procedures. The current product portfolio includes Cleaner™ Rotational Thrombectomy System, JAWZ™ Endomyocardial Biopsy Forceps, and the soon to be released, UltraStream™ Chronic Dialysis Catheter. Argon is a portfolio company of Roundtable Healthcare Partners.

About Roundtable

About Rex Medical, LP

Argon Medical Devices announces Exclusive License and Distribution Agreement for UltraStream Chronic Hemodialysis Catheter

ecarlist — Tue, 16 Nov 2010 00:01:25 +0000

Argon Medical Devices, Inc. announced that it has entered into a definitive licensing agreement with Rex Medical, LP (“Rex Medical”) for exclusive rights to market and distribute the UltraStream chronic dialysis catheter ™ on a global basis. UltraStream™ is designed to provide long-term vascular access to patients receiving dialysis treatments.

Argon exhibited at the recent 37th Veithsymposium™ to be held in New York City.

“The addition of UltraStream™ reinforces our commitment to providing physicians with innovative products focused on improving patient care,” said George A. Leondis, President of Argon Medical Devices, Inc. “We are excited about this opportunity to further enhance our portfolio of products for use in the area of dialysis access, which also includes the Cleaner™ Rotational Thrombectomy System.”

There are over 500,000 patients currently undergoing treatment in the U.S. for End-Stage Renal Disease (ESRD). It is estimated that the dialysis patient population will continue to grow at a rate exceeding 6% annually.

About Argon

About Roundtable

About Rex Medical, LP

CONTACT: Christian Chilcott of Argon Medical Devices, Inc., Phone: +1-903-675-9321 email: christian.chilcott@argonmedical.com

RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms from BD

argon_admin — Mon, 04 Oct 2010 00:01:10 +0000

Acquisition Positions Argon as a Leading Provider of Products in Interventional Radiology, Critical Care and Cardiac Catheterization Markets

LAKE FOREST, IL, October 4, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon”), has acquired the critical care and extended dwell catheter product platforms consisting of blood pressure monitoring devices, and central venous, pulmonary artery and extended dwell catheters from BD (Becton, Dickinson and Company). Argon is a global manufacturer and marketer of single-use specialty medical devices for procedures in Interventional Radiology, Interventional Cardiology, and Critical Care.

The acquisition of the Critical Care and Extended Dwell Catheter product platforms further positions Argon as a leading provider of vascular access products by joining Argon’s other products including Cleaner^TM Rotational Thrombectomy System, JAWZ™ Endomyocardial Biopsy Forceps, pressure transducers, high pressure manifolds and vascular introducer kits. The company’s products are sold through a combination of direct sales representatives and specialty distributors in the United States and a network of leading distributors internationally.

As part of the transaction, Argon also acquired a dedicated state-of-the-art facility in Yishun, Singapore. Argon manufactures its other products in facilities in Athens, TX.

“The BD pressure monitoring and catheter products are well recognized by hospitals and physicians worldwide,” said Michael J. Hudson, CEO of Argon. “The acquisition of these well-recognized products rounds out the Argon portfolio giving us a significant global presence in these important markets.”

“The global nature of this product platform makes this acquisition particularly complex,” said Joseph F. Damico, Founding Partner and Co-Chairman of RoundTable. “RoundTable’s in-house resources in sales, manufacturing, IT and human resources are working closely with the Argon team to effectively integrate the operations of these two businesses and position Argon for growth.”

As part of the transaction, and to finance further growth opportunities for Argon, RoundTable facilitated the successful completion of new senior credit facilities and a private placement of subordinated notes. The senior credit facilities were led by GE Commercial Finance Healthcare Financial Services. Argon’s subordinated notes were acquired by RoundTable Capital Partners (“Capital Fund I”), RoundTable’s captive subordinated debt fund. Capital Fund I is a dedicated subordinated debt fund that makes fixed rate subordinated debt investments alongside the equity investments of RoundTable’s equity funds. RoundTable and certain other investors made an equity investment in Argon as part of the transaction.

Argon Medical Devices and Rex Medical Announce Exclusive License and Distribution Agreement for the “CLEANER™” Rotational Thrombectomy System

argon_admin — Wed, 10 Mar 2010 00:01:55 +0000

ATHENS, TX, March 9, 2010 – Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP (“Rex Medical”) for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

Argon and Rex Medical will be exhibiting at the 34^th Annual Meeting of the Society of Interventional

Radiology (SIR) to be held in Tampa, FL from March 14-17, 2008.

“We are excited to partner with Rex Medical on this innovative technology. Preserving dialysis access is one of the most challenging therapeutic issues within the vascular access arena. The launch of Cleaner will provide a fast, effective method for declotting occluded vessels and grafts,” said George Leondis, President of Argon Medical. “This is a significant step forward in Argon’s strategy to provide unique solutions to the interventional space, and we are confident this ‘best in class’ product will quickly become a leading technology in this fast-growing market segment.

About the Cleaner™ Rotational Thrombectomy System

Cleaner™ technology is an ergonomically designed, percutaneous 6Fr catheter based system (single piece construction) that is compatible with a 6Fr introducer sheath. A disposable, battery operated hand held drive unit is attached to a wire and rotates at a low speed (4000 RPM). The distal, sinuous shaped tip of the wire facilitates atraumatic mechanical declotting of occluded native vessel fistulae and synthetic dialysis access grafts. The outer catheter distal tip and sinuous wire segment are both radiopaque for fluoroscopic visualization.

According to the company, Cleaner™ technology provides the physician base with superior trackability and steerability. This quiet and easy to use system has the ability to effectively operate, negotiate and macerate thrombus around the graft apex and opposing sheath

There are over 500,000 patients currently undergoing treatment in the U.S. for End-Stage Renal Disease (ESRD). In addition, over 300,000 procedures are being performed annually in the U.S. to repair and clear thrombosed hemodialysis access grafts and fistulae. It is estimated that the dialysis patient population will continue to grow at a rate exceeding 6% annually.

About Argon

Argon Medical Devices, Inc. based in Athens, TX, is a privately-held global medical device company which manufactures and markets solutions for cardiovascular procedures. It is a subsidiary of ACI Holdings, a portfolio company of Roundtable Healthcare Partners

About Roundtable

About Rex Medical, LP